iTonic Holdings Ltd. - Asset Resilience Ratio
iTonic Holdings Ltd. (ITOC) has an Asset Resilience Ratio of 15.79% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how financially flexible is iTonic Holdings Ltd. to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how iTonic Holdings Ltd.'s Asset Resilience Ratio has changed over time. See how leveraged is iTonic Holdings Ltd.'s balance sheet to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down iTonic Holdings Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ITOC market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.44 Million | 15.79% |
| Total Liquid Assets | $1.44 Million | 15.79% |
Asset Resilience Insights
- Good Liquidity Position: iTonic Holdings Ltd. maintains a healthy 15.79% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
iTonic Holdings Ltd. Industry Peers by Asset Resilience Ratio
Compare iTonic Holdings Ltd.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for iTonic Holdings Ltd. (2024–2025)
The table below shows the annual Asset Resilience Ratio data for iTonic Holdings Ltd..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 15.79% | $1.44 Million | $9.10 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $6.72 Million | -- |
About iTonic Holdings Ltd.
iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a t… Read more